Stock 600763 TOPCHOICE MEDICAL CO., INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Topchoice Medical Co., Inc.

Equities

600763

CNE000000MZ8

Healthcare Facilities & Services

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-04-28 EDT 		5-day change 1st Jan Change
61.03 CNY +0.98% Intraday chart for Topchoice Medical Co., Inc. +15.76% -20.17%
04-25 Topchoice Medical Co., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-25 Topchoice Medical Co., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 32,875 88,663 63,807 49,055 24,513 19,569 - -
Enterprise Value (EV) 1 32,773 88,275 63,240 48,594 24,327 18,586 17,486 17,526
P/E ratio 71.2 x 180 x 90.9 x 89.5 x 49 x 34.2 x 24.4 x 24.4 x
Yield - - - - 0.57% 0.09% - -
Capitalization / Revenue 17.4 x 42.5 x 22.9 x 18 x 8.61 x 6.17 x 5.06 x 4.68 x
EV / Revenue 17.3 x 42.3 x 22.7 x 17.9 x 8.55 x 5.86 x 4.52 x 4.19 x
EV / EBITDA 45.5 x 114 x 58.5 x 56.4 x 28.5 x 16.8 x 13.6 x 13 x
EV / FCF - - 111 x 195 x 72.7 x 33.2 x 26.5 x 18.9 x
FCF Yield - - 0.9% 0.51% 1.38% 3.01% 3.77% 5.3%
Price to Book 18.4 x 41.2 x 22.2 x 14.8 x 6.44 x 4.39 x 3.58 x 3.26 x
Nbr of stocks (in thousands) 320,640 320,640 320,640 320,640 320,640 320,640 - -
Reference price 2 102.5 276.5 199.0 153.0 76.45 61.03 61.03 61.03
Announcement Date 20-04-23 21-04-09 22-04-27 23-04-27 24-04-25 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,894 2,088 2,781 2,719 2,847 3,170 3,864 4,181
EBITDA 1 720.2 771.5 1,081 861.6 852.4 1,107 1,290 1,346
EBIT 1 633.8 678.6 974.9 733.9 711.9 782.4 1,091 1,113
Operating Margin 33.46% 32.5% 35.06% 27% 25.01% 24.68% 28.22% 26.62%
Earnings before Tax (EBT) 1 633.4 680.1 974.6 738 708.9 801.3 1,100 1,139
Net income 1 463.1 492.6 702.8 548.3 500.5 572.9 800.8 802.5
Net margin 24.45% 23.59% 25.27% 20.17% 17.58% 18.07% 20.72% 19.19%
EPS 2 1.440 1.540 2.190 1.710 1.560 1.787 2.499 2.500
Free Cash Flow 1 - - 572.1 249.1 334.5 559 660 929
FCF margin - - 20.57% 9.16% 11.75% 17.64% 17.08% 22.22%
FCF Conversion (EBITDA) - - 52.91% 28.92% 39.24% 50.5% 51.17% 69.04%
FCF Conversion (Net income) - - 81.4% 45.44% 66.84% 97.58% 82.42% 115.76%
Dividend per Share 2 - - - - 0.4350 0.0555 - -
Announcement Date 20-04-23 21-04-09 22-04-27 23-04-27 24-04-25 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 663.5 821.2 579.2 674.5 688.1 822.2 661.7 708.4 758.1 904.6 716.3
EBITDA - - - - - - - - - - - -
EBIT 1 - 175.1 282 51.96 225 176.8 282.4 27.71 - 170.6 300.4 81.54
Operating Margin - 26.38% 34.34% 8.97% 33.36% 25.69% 34.35% 4.19% - 22.51% 33.2% 11.38%
Earnings before Tax (EBT) - - - 51.38 224.7 176.2 282.1 - - - - -
Net income 166.5 - - 33.1 169 135.4 207.3 - - - - -
Net margin - - - 5.71% 25.05% 19.68% 25.22% - - - - -
EPS 2 0.5200 0.4000 0.6900 0.1000 0.5300 0.4200 0.6500 -0.0400 0.5400 0.4200 0.7100 0.1100
Dividend per Share - - - - - - - - - - - -
Announcement Date 22-04-27 22-08-22 22-10-24 23-04-27 23-04-27 23-08-24 23-10-24 24-04-25 24-04-25 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 103 389 568 461 186 982 2,083 2,043
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - 572 249 335 559 660 929
ROE (net income / shareholders' equity) 29.9% 24.4% 27.9% 17.6% 14.1% 13.6% 15.7% 14.7%
ROA (Net income/ Total Assets) 19.3% 17.1% 17.5% 10.8% - 8.9% 9.87% -
Assets 1 2,396 2,877 4,010 5,055 - 6,437 8,116 -
Book Value Per Share 2 5.570 6.710 8.980 10.30 11.90 13.90 17.00 18.70
Cash Flow per Share 2 2.020 2.210 2.930 2.090 2.620 2.870 3.250 -
Capex 1 126 166 367 421 505 381 248 380
Capex / Sales 6.64% 7.94% 13.21% 15.48% 17.76% 12.02% 6.41% 9.09%
Announcement Date 20-04-23 21-04-09 22-04-27 23-04-27 24-04-25 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Topchoice Medical Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
61.03 CNY
Average target price
80.8 CNY
Spread / Average Target
+32.39%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Doctor's Office

1st Jan change Capi.
TOPCHOICE MEDICAL CO., INC. Stock Topchoice Medical Co., Inc.
-20.17% 2.7B
HUAXIA EYE HOSPITAL GROUP CO.,LTD. Stock Huaxia Eye Hospital Group Co.,Ltd.
-18.39% 3.02B
AGILON HEALTH, INC. Stock agilon health, inc.
-59.67% 2.11B
AIRSCULPT TECHNOLOGIES, INC. Stock AirSculpt Technologies, Inc.
-25.50% 321M
EUROEYES INTERNATIONAL EYE CLINIC LIMITED Stock EuroEyes International Eye Clinic Limited
+2.88% 221M
MEDSCI HEALTHCARE HOLDINGS LIMITED Stock MedSci Healthcare Holdings Limited
-46.12% 177M
AESTHETIC CONNECT Stock Aesthetic Connect
-27.37% 123M
Doctor's Office
  1. Stock Market
  2. Equities
  3. 600763 Stock
  4. Financials Topchoice Medical Co., Inc.